Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study
At present, there are few reports that have clarified the effectiveness of 23-valent pneumococcal polysaccharide vaccine (PPSV23) against all-cause pneumonia or pneumococcal pneumonia in community-acquired pneumonia (CAP) in older individuals in Japan. We conducted a hospital-based matched case-cont...
Saved in:
Main Authors: | Kanzo Suzuki (Author), Kyoko Kondo (Author), Masakazu Washio (Author), Kei Nakashima (Author), Sakae Kan (Author), Seiichiro Imai (Author), Kunihiko Yoshimura (Author), Chiharu Ota (Author), Satoko Ohfuji (Author), Wakaba Fukushima (Author), Yoshio Hirota (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategies for pneumococcal vaccination in older adults in the coming era
by: Kei Nakashima, et al.
Published: (2024) -
Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy
by: Kei Nakashima, et al.
Published: (2017) -
Survey of pediatricians concerning the human papillomavirus vaccine in Japan: Positive attitudes toward vaccination during the period of proactive recommendation being withheld
by: Megumi Kubota, et al.
Published: (2022) -
Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial
by: Kei Nakashima, et al.
Published: (2018) -
Real-world vaccine effectiveness of mRNA vaccines for SARS-CoV-2; a test-negative case-control study in a medium-sized clinic
by: Masahiro Aoshima, et al.
Published: (2022)